Donate

Nursing Webinar Clinical Trials P2 ‘The Role of Nurses In Clinical Trials’

This is part two of a three part mini-series aimed to enhance nursing knowledge of clinical trials.

This webinar will be presented by Clinical Nurse Consultant/Senior Research Nurse Molly Robertson.

Molly is a clinical nurse consultant/senior research nurse in haematology at the Parkville Cancer Clinical Trial Unit at Peter MacCallum. She has worked in haematology nursing for the last 8 years. This includes acute leukaemia, auto and allo stem cell transplants and aggressive lymphoma. In the clinical trial space, Molly has worked on first in human, phase 1, 2 and 3 clinical trials.

 

Molly has a passion for working in the CAR-T and Bispecific clinical trial space as well as providing ongoing education to fellow nurses in this area.

 

There is limited availability for this event, so secure your spot quickly.
This event has already taken place.
Details
Date: Wednesday 20th of September 2023
Time: 6:00pm AEST - 7:00pm AEST

Support and information

Patient Online Forum

Find Out More

Order Our Resources

Find Out More

Fundraise for us

Get started

Sign up to our Newsletter

Back to top
Sign Up
About Us
Lymphoma
Patients
Get Involved
Lymphoma Australia is the only incorporated charity in Australia dedicated to solely providing education, support, awareness and advocacy initiatives for Australians touched by lymphoma and chronic lymphocytic leukemia (CLL).
Copyright © 2025. Lymphoma Australia
Linkedin Spotify
Contact Us
Cart
Checkout - $0.00
  • 0
  • 1

Contact Lymphoma Australia Today!

Patient Support Hotline

General Enquiries

Please note: Lymphoma Australia staff are only able to reply to emails sent in English language.

For people living in Australia, we can offer a phone translation service. Have your nurse or English speaking relative call us to arrange this.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.